Unveiling Teladoc (TDOC) Q3 Outlook: Wall Street Estimates for Key Metrics

Zacks
Open on Zacks
Unveiling Teladoc (TDOC) Q3 Outlook: Wall Street Estimates for Key Metrics

The upcoming report from Teladoc (TDOC) is expected to reveal quarterly loss of -$0.23 per share, indicating a decline of 9.5% compared to the year-ago period. Analysts forecast revenues of $585.55 million, representing a decline of 6.5% year over year.

Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

With that in mind, let's delve into the average projections of some Teladoc metrics that are commonly tracked and projected by analysts on Wall Street.

The combined assessment of analysts suggests that 'Revenues by Segment- Integrated Care' will likely reach $394.98 million. The estimate indicates a year-over-year change of +1.4%.

It is projected by analysts that the 'Revenues by Segment- BetterHelp' will reach $192.32 million. The estimate indicates a change of -18.8% from the prior-year quarter.

Analysts expect 'U.S. Integrated Care Members' to come in at 99.76 million. Compared to the current estimate, the company reported 102.50 million in the same quarter of the previous year.

The consensus among analysts is that 'Adjusted EBITDA- BetterHelp' will reach $1.67 million. The estimate is in contrast to the year-ago figure of $3.84 million.

The average prediction of analysts places 'Adjusted EBITDA- Integrated Care' at $63.49 million. The estimate compares to the year-ago value of $66.07 million.

View all Key Company Metrics for Teladoc here>>>

Over the past month, shares of Teladoc have returned +5.9% versus the Zacks S&P 500 composite's -0.8% change. Currently, TDOC carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Radical New Technology Could Hand Investors Huge Gains

Quantum Computing is the next technological revolution, and it could be even more advanced than AI.

While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.

Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power .

Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.

See Top Quantum Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Teladoc Health, Inc. (TDOC): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research